𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thorax perfusion CT in non-small cell lung cancer

✍ Scribed by Gulgun Yilmaz Ovali; Aysin Sakar; Cihan Göktan; Pınar Çelik; Arzu Yorgancıoğlu; Nalân Nese; Yüksel Pabuscu

Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
397 KB
Volume
31
Category
Article
ISSN
0895-6111

No coin nor oath required. For personal study only.

✦ Synopsis

Objectives: We aimed to determine the perfusion differences according to the histological type, stage, volume and prognoses in the non-small cell carcinoma by thorax perfusion CT. Materials and methods: Twenty-four non-small cell carcinoma patients were included in the study. Thorax perfusion CT was done to evaluate the tumors in terms of perfusion parameters: blood flow (BF) and time to peak (TTP) values.

Results:

The total blood flow of the tumor in squamous cell carcinoma was significantly higher than adenocarcinoma (p = 0.031). There was no statistical difference between the perfusion parameters and other parameters. Conclusions: Perfusion CT may help us in evaluating non-small cell carcinomas.

📜 SIMILAR VOLUMES

HMGA2 overexpression in non-small cell l
HMGA2 overexpression in non-small cell lung cancer
✍ Britta Meyer; Siegfried Loeschke; Anke Schultze; Thomas Weigel; Martin Sandkamp; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 1 views

## Abstract Lung cancer is still the leading cause of death from cancer worldwide primarily because of the fact that most lung cancers are diagnosed at advanced stages. Overexpression of the high mobility group protein HMGA2 has been observed in a variety of malignant tumors and often correlates wi

Contemporary brachytherapy approaches in
Contemporary brachytherapy approaches in non–small-cell lung cancer
✍ Hilaris, Basil S.; Mastoras, Dina A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Brachytherapy has the ability to deliver a higher tumor dose compared to external beam irradiation, while sparing normal tissue outside the tumor; it is the most effective means of delivering conformal radiation and can be tailored to clinical circumstances, either at open surgery or in an ambulator

Simultaneous chemoradiation in advanced
Simultaneous chemoradiation in advanced non-small cell lung cancer
✍ Julianna Pisch; Stephen Malamud; James Harvey; Edward J. Beattie 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

We designed our study to evaluate the safety and efficacy of simultaneous chemoradiation therapy in an accelerated, twice-a-day schedule to improve local control and survival in advanced lung cancer patients. Forty-one patients were entered into the study. Twenty-three had stage IIIB and 18 had stag

Tumor angiogenesis of non–small cell lun
Tumor angiogenesis of non–small cell lung cancer
✍ Noriharu Shijubo; Hiroshi Kojima; Manabu Nagata; Takashi Ohchi; Akihiro Suzuki; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract Lung cancer is one of the commonest causes of cancer death in developed countries. Recent evidence suggests that angoigenesis is related to poor prognosis in many solid tumors including non–small cell lung cancer (NSCLC). Angiogenesis is regulated by a complex interaction among growth f

Adjuvant therapy of non-small cell lung
Adjuvant therapy of non-small cell lung cancer
✍ E. Carmack Holmes 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

One hundred and forty thousand patients in the United States will develop lung cancer annually. About one half of these will have disease confined to the thorax with no clinical evidence of dissemination (Figure 1). A relatively high proportion of these patients will actually have disease that can b